Industry Research Reports
Home > Reports > Chemical & Material > Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Chemical & Material
Published Date: 2026-06-16
Pages: 126 Pages
Report ld: 6750196
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Lasmiditan Succinate cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
The North American market for Lasmiditan Succinate was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Lasmiditan Succinate was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Lasmiditan Succinate was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Lasmiditan Succinate market include Molnova, Excenen Pharmatech, Hubei Gedian Humanwell Pharma, Nantong HI-FUTURE Biology, ShiJiaZhuang Chirals Chemical, Shenzhen Shengda Pharma Limited, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Lasmiditan Succinate, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Lasmiditan Succinate market size, estimations, and forecasts are presented in terms of sales volume (Kg) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Lasmiditan Succinate.
MARKET SEGMENTATION
By Company
- Molnova
- Excenen Pharmatech
- Hubei Gedian Humanwell Pharma
- Nantong HI-FUTURE Biology
- ShiJiaZhuang Chirals Chemical
- Shenzhen Shengda Pharma Limited
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity ≥98%
- Purity ≥99%
Segment by Application
- Tablet
- Oral Liquid
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Lasmiditan Succinate manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Lasmiditan Succinate sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Lasmiditan Succinate sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Lasmiditan Succinate Product Introduction
1.2 Global Lasmiditan Succinate Market Size Forecast
1.2.1 Global Lasmiditan Succinate Sales Value (2021–2032)
1.2.2 Global Lasmiditan Succinate Sales Volume (2021–2032)
1.2.3 Global Lasmiditan Succinate Sales Price (2021–2032)
1.3 Lasmiditan Succinate Market Trends & Drivers
1.3.1 Lasmiditan Succinate Industry Trends
1.3.2 Lasmiditan Succinate Market Drivers & Opportunities
1.3.3 Lasmiditan Succinate Market Challenges
1.3.4 Lasmiditan Succinate Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Lasmiditan Succinate Players Revenue Ranking (2025)
2.2 Global Lasmiditan Succinate Revenue by Company (2021–2026)
2.3 Global Lasmiditan Succinate Sales Volume Ranking of Players (2025)
2.4 Global Lasmiditan Succinate Sales Volume by Company (2021–2026)
2.5 Global Lasmiditan Succinate Average Price by Company (2021–2026)
2.6 Key Manufacturers Lasmiditan Succinate Manufacturing Base and Headquarters
2.7 Key Manufacturers Lasmiditan Succinate Product Offerings
2.8 Key Manufacturers Start of Mass Production of Lasmiditan Succinate
2.9 Lasmiditan Succinate Market Competitive Analysis
2.9.1 Lasmiditan Succinate Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Lasmiditan Succinate Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Lasmiditan Succinate revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Lasmiditan Succinate Market Classification
3.1 Introduction by Type
3.1.1 Purity ≥98%
3.1.2 Purity ≥99%
3.1.3 Global Lasmiditan Succinate Sales Value by Type
3.1.3.1 Global Lasmiditan Succinate Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Lasmiditan Succinate Sales Value, by Type (2021–2032)
3.1.3.3 Global Lasmiditan Succinate Sales Value, by Type (%), 2021–2032
3.1.4 Global Lasmiditan Succinate Sales Volume by Type
3.1.4.1 Global Lasmiditan Succinate Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Lasmiditan Succinate Sales Volume, by Type (2021–2032)
3.1.4.3 Global Lasmiditan Succinate Sales Volume, by Type (%), 2021–2032
3.1.5 Global Lasmiditan Succinate Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Oral Liquid
4.2 Global Lasmiditan Succinate Sales Value by Application
4.2.1 Global Lasmiditan Succinate Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Lasmiditan Succinate Sales Value, by Application (2021–2032)
4.2.3 Global Lasmiditan Succinate Sales Value, by Application (%), 2021–2032
4.3 Global Lasmiditan Succinate Sales Volume by Application
4.3.1 Global Lasmiditan Succinate Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Lasmiditan Succinate Sales Volume, by Application (2021–2032)
4.3.3 Global Lasmiditan Succinate Sales Volume, by Application (%), 2021–2032
4.4 Global Lasmiditan Succinate Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Lasmiditan Succinate Sales Value by Region
5.1.1 Global Lasmiditan Succinate Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Lasmiditan Succinate Sales Value by Region (2021–2026)
5.1.3 Global Lasmiditan Succinate Sales Value by Region (2027–2032)
5.1.4 Global Lasmiditan Succinate Sales Value by Region (%), 2021–2032
5.2 Global Lasmiditan Succinate Sales Volume by Region
5.2.1 Global Lasmiditan Succinate Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Lasmiditan Succinate Sales Volume by Region (2021–2026)
5.2.3 Global Lasmiditan Succinate Sales Volume by Region (2027–2032)
5.2.4 Global Lasmiditan Succinate Sales Volume by Region (%), 2021–2032
5.3 Global Lasmiditan Succinate Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Lasmiditan Succinate Sales Value, 2021–2032
5.4.2 North America Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Lasmiditan Succinate Sales Value, 2021–2032
5.5.2 Europe Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Lasmiditan Succinate Sales Value, 2021–2032
5.6.2 Asia Pacific Lasmiditan Succinate Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Lasmiditan Succinate Sales Value, 2021–2032
5.7.2 South America Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Lasmiditan Succinate Sales Value, 2021–2032
5.8.2 Middle East & Africa Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Lasmiditan Succinate Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Lasmiditan Succinate Sales Value and Sales Volume
6.2.1 Key Countries/Regions Lasmiditan Succinate Sales Value, 2021–2032
6.2.2 Key Countries/Regions Lasmiditan Succinate Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Lasmiditan Succinate Sales Value, 2021–2032
6.3.2 United States Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Lasmiditan Succinate Sales Value, 2021–2032
6.4.2 Europe Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Lasmiditan Succinate Sales Value, 2021–2032
6.5.2 China Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.5.3 China Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Lasmiditan Succinate Sales Value, 2021–2032
6.6.2 Japan Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Lasmiditan Succinate Sales Value, 2021–2032
6.7.2 South Korea Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Lasmiditan Succinate Sales Value, 2021–2032
6.8.2 Southeast Asia Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Lasmiditan Succinate Sales Value, 2021–2032
6.9.2 India Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
6.9.3 India Lasmiditan Succinate Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Molnova
7.1.1 Molnova Company Information
7.1.2 Molnova Introduction and Business Overview
7.1.3 Molnova Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Molnova Lasmiditan Succinate Product Offerings
7.1.5 Molnova Recent Developments
7.2 Excenen Pharmatech
7.2.1 Excenen Pharmatech Company Information
7.2.2 Excenen Pharmatech Introduction and Business Overview
7.2.3 Excenen Pharmatech Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Excenen Pharmatech Lasmiditan Succinate Product Offerings
7.2.5 Excenen Pharmatech Recent Developments
7.3 Hubei Gedian Humanwell Pharma
7.3.1 Hubei Gedian Humanwell Pharma Company Information
7.3.2 Hubei Gedian Humanwell Pharma Introduction and Business Overview
7.3.3 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Product Offerings
7.3.5 Hubei Gedian Humanwell Pharma Recent Developments
7.4 Nantong HI-FUTURE Biology
7.4.1 Nantong HI-FUTURE Biology Company Information
7.4.2 Nantong HI-FUTURE Biology Introduction and Business Overview
7.4.3 Nantong HI-FUTURE Biology Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Nantong HI-FUTURE Biology Lasmiditan Succinate Product Offerings
7.4.5 Nantong HI-FUTURE Biology Recent Developments
7.5 ShiJiaZhuang Chirals Chemical
7.5.1 ShiJiaZhuang Chirals Chemical Company Information
7.5.2 ShiJiaZhuang Chirals Chemical Introduction and Business Overview
7.5.3 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Product Offerings
7.5.5 ShiJiaZhuang Chirals Chemical Recent Developments
7.6 Shenzhen Shengda Pharma Limited
7.6.1 Shenzhen Shengda Pharma Limited Company Information
7.6.2 Shenzhen Shengda Pharma Limited Introduction and Business Overview
7.6.3 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Product Offerings
7.6.5 Shenzhen Shengda Pharma Limited Recent Developments
8 Industry Chain Analysis
8.1 Lasmiditan Succinate Industrial Chain
8.2 Lasmiditan Succinate Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Lasmiditan Succinate Sales Model
8.5.2 Sales Channels
8.5.3 Lasmiditan Succinate Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Lasmiditan Succinate Market Trends
Table 2. Lasmiditan Succinate Market Drivers & Opportunities
Table 3. Lasmiditan Succinate Market Challenges
Table 4. Lasmiditan Succinate Market Restraints
Table 5. Global Lasmiditan Succinate Revenue by Company (US$ Million), 2021–2026
Table 6. Global Lasmiditan Succinate Revenue Market Share by Company (2021–2026)
Table 7. Global Lasmiditan Succinate Sales Volume by Company (Kg), 2021–2026
Table 8. Global Lasmiditan Succinate Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Lasmiditan Succinate Price by Company (US$/g), 2021–2026
Table 10. Key Manufacturers Lasmiditan Succinate Manufacturing Base and Headquarters
Table 11. Key Manufacturers Lasmiditan Succinate Product Type
Table 12. Key Manufacturers Start of Mass Production of Lasmiditan Succinate
Table 13. Global Lasmiditan Succinate Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Lasmiditan Succinate revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Lasmiditan Succinate Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Lasmiditan Succinate Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Lasmiditan Succinate Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Lasmiditan Succinate Sales Market Share in Value by Type (2021–2026)
Table 20. Global Lasmiditan Succinate Sales Market Share in Value by Type (2027–2032)
Table 21. Global Lasmiditan Succinate Sales Volume by Type: 2021 vs 2025 vs 2032 (Kg)
Table 22. Global Lasmiditan Succinate Sales Volume by Type (Kg), 2021–2026
Table 23. Global Lasmiditan Succinate Sales Volume by Type (Kg), 2027–2032
Table 24. Global Lasmiditan Succinate Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Lasmiditan Succinate Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Lasmiditan Succinate Price by Type (US$/g), 2021–2026
Table 27. Global Lasmiditan Succinate Price by Type (US$/g), 2027–2032
Table 28. Global Lasmiditan Succinate Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Lasmiditan Succinate Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Lasmiditan Succinate Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Lasmiditan Succinate Sales Market Share in Value by Application (2021–2026)
Table 32. Global Lasmiditan Succinate Sales Market Share in Value by Application (2027–2032)
Table 33. Global Lasmiditan Succinate Sales Volume by Application: 2021 vs 2025 vs 2032 (Kg)
Table 34. Global Lasmiditan Succinate Sales Volume by Application (Kg), 2021–2026
Table 35. Global Lasmiditan Succinate Sales Volume by Application (Kg), 2027–2032
Table 36. Global Lasmiditan Succinate Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Lasmiditan Succinate Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Lasmiditan Succinate Price by Application (US$/g), 2021–2026
Table 39. Global Lasmiditan Succinate Price by Application (US$/g), 2027–2032
Table 40. Global Lasmiditan Succinate Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Lasmiditan Succinate Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Lasmiditan Succinate Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Lasmiditan Succinate Sales Value by Region (%), 2021–2026
Table 44. Global Lasmiditan Succinate Sales Value by Region (%), 2027–2032
Table 45. Global Lasmiditan Succinate Sales Volume by Region (Kg): 2021 vs 2025 vs 2032
Table 46. Global Lasmiditan Succinate Sales Volume by Region (Kg), 2021–2026
Table 47. Global Lasmiditan Succinate Sales Volume by Region (Kg), 2027–2032
Table 48. Global Lasmiditan Succinate Sales Volume by Region (%), 2021–2026
Table 49. Global Lasmiditan Succinate Sales Volume by Region (%), 2027–2032
Table 50. Global Lasmiditan Succinate Average Price by Region (US$/g), 2021–2026
Table 51. Global Lasmiditan Succinate Average Price by Region (US$/g), 2027–2032
Table 52. Key Countries/Regions Lasmiditan Succinate Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Lasmiditan Succinate Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Lasmiditan Succinate Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Lasmiditan Succinate Sales Volume, (Kg), 2021–2026
Table 56. Key Countries/Regions Lasmiditan Succinate Sales Volume, (Kg), 2027–2032
Table 57. Molnova Company Information
Table 58. Molnova Introduction and Business Overview
Table 59. Molnova Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
Table 60. Molnova Lasmiditan Succinate Product Offerings
Table 61. Molnova Recent Developments
Table 62. Excenen Pharmatech Company Information
Table 63. Excenen Pharmatech Introduction and Business Overview
Table 64. Excenen Pharmatech Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
Table 65. Excenen Pharmatech Lasmiditan Succinate Product Offerings
Table 66. Excenen Pharmatech Recent Developments
Table 67. Hubei Gedian Humanwell Pharma Company Information
Table 68. Hubei Gedian Humanwell Pharma Introduction and Business Overview
Table 69. Hubei Gedian Humanwell Pharma Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
Table 70. Hubei Gedian Humanwell Pharma Lasmiditan Succinate Product Offerings
Table 71. Hubei Gedian Humanwell Pharma Recent Developments
Table 72. Nantong HI-FUTURE Biology Company Information
Table 73. Nantong HI-FUTURE Biology Introduction and Business Overview
Table 74. Nantong HI-FUTURE Biology Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
Table 75. Nantong HI-FUTURE Biology Lasmiditan Succinate Product Offerings
Table 76. Nantong HI-FUTURE Biology Recent Developments
Table 77. ShiJiaZhuang Chirals Chemical Company Information
Table 78. ShiJiaZhuang Chirals Chemical Introduction and Business Overview
Table 79. ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
Table 80. ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Product Offerings
Table 81. ShiJiaZhuang Chirals Chemical Recent Developments
Table 82. Shenzhen Shengda Pharma Limited Company Information
Table 83. Shenzhen Shengda Pharma Limited Introduction and Business Overview
Table 84. Shenzhen Shengda Pharma Limited Lasmiditan Succinate Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021–2026)
Table 85. Shenzhen Shengda Pharma Limited Lasmiditan Succinate Product Offerings
Table 86. Shenzhen Shengda Pharma Limited Recent Developments
Table 87. Key Raw Materials Lists
Table 88. Key Suppliers of Raw Materials Lists
Table 89. Lasmiditan Succinate Downstream Customers
Table 90. Lasmiditan Succinate Distributors List
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Lasmiditan Succinate Product Picture
Figure 2. Global Lasmiditan Succinate Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 4. Global Lasmiditan Succinate Sales Volume (Kg), 2021–2032
Figure 5. Global Lasmiditan Succinate Sales Price (US$/g), 2021–2032
Figure 6. Lasmiditan Succinate Report Years Considered
Figure 7. Global Lasmiditan Succinate Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Lasmiditan Succinate Sales Volume Ranking of Players (Kg), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lasmiditan Succinate Revenue in 2025
Figure 10. Lasmiditan Succinate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Purity ≥98% Picture
Figure 12. Purity ≥99% Picture
Figure 13. Global Lasmiditan Succinate Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Lasmiditan Succinate Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Lasmiditan Succinate Sales Volume by Type (Kg), 2021 vs 2025 vs 2032
Figure 16. Global Lasmiditan Succinate Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Lasmiditan Succinate Price by Type (US$/g), 2021–2032
Figure 18. Product Picture of Tablet
Figure 19. Product Picture of Oral Liquid
Figure 20. Global Lasmiditan Succinate Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Lasmiditan Succinate Sales Value Market Share by Application, 2025 & 2032
Figure 22. Global Lasmiditan Succinate Sales Volume by Application (Kg), 2021 vs 2025 vs 2032
Figure 23. Global Lasmiditan Succinate Sales Volume Market Share by Application, 2025 & 2032
Figure 24. Global Lasmiditan Succinate Price by Application (US$/g), 2021–2032
Figure 25. North America Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 26. North America Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
Figure 27. Europe Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 28. Europe Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
Figure 29. Asia Pacific Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 30. Asia Pacific Lasmiditan Succinate Sales Value by Region (%), 2025 vs 2032
Figure 31. South America Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 32. South America Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
Figure 33. Middle East & Africa Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 34. Middle East & Africa Lasmiditan Succinate Sales Value by Country (%), 2025 vs 2032
Figure 35. Key Countries/Regions Lasmiditan Succinate Sales Value (%), 2021–2032
Figure 36. Key Countries/Regions Lasmiditan Succinate Sales Volume (%), 2021–2032
Figure 37. United States Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 38. United States Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 39. United States Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 40. Europe Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 41. Europe Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 42. Europe Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 43. China Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 44. China Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 45. China Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 46. Japan Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 47. Japan Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 48. Japan Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 49. South Korea Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 50. South Korea Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 51. South Korea Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 52. Southeast Asia Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 53. Southeast Asia Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 54. Southeast Asia Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 55. India Lasmiditan Succinate Sales Value (US$ Million), 2021–2032
Figure 56. India Lasmiditan Succinate Sales Value by Type (%), 2025 vs 2032
Figure 57. India Lasmiditan Succinate Sales Value by Application (%), 2025 vs 2032
Figure 58. Lasmiditan Succinate Industrial Chain
Figure 59. Lasmiditan Succinate Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Lasmiditan Succinate market?
The top companies in the global Lasmiditan Succinate market are Molnova、Excenen Pharmatech、Hubei Gedian Humanwell Pharma.
Related Reports
Global Lasmiditan Succinate Market Research Report 2026
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 127
USD 2900.00
(Single User License)
Global Lasmiditan Succinate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 80
USD 4250.00
(Single User License)
Global Lasmiditan Succinate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 137
USD 4900.00
(Single User License)
Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 93
USD 3950.00
(Single User License)
Global Lasmiditan Succinate Market Research Report 2025
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 93
USD 2900.00
(Single User License)
Global Lasmiditan Succinate Market Insights, Forecast to 2030
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-04-15
Pages: 90
USD 4900.00
(Single User License)
Global Lasmiditan Succinate Market Research Report 2024
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-01-17
Pages: 92
USD 2900.00
(Single User License)
Global Lasmiditan Succinate Market Research Report 2026
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 127
USD 2900.00 (Single User License)Global Lasmiditan Succinate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 80
USD 4250.00 (Single User License)Global Lasmiditan Succinate Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 137
USD 4900.00 (Single User License)Lasmiditan Succinate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 93
USD 3950.00 (Single User License)Global Lasmiditan Succinate Market Research Report 2025
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 93
USD 2900.00 (Single User License)Global Lasmiditan Succinate Market Insights, Forecast to 2030
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-04-15
Pages: 90
USD 4900.00 (Single User License)Global Lasmiditan Succinate Market Research Report 2024
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-01-17
Pages: 92
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now